AZD8701
Based on 1 Customer Validation
AZD8701 (IONIS-1063734) is an antisense oligonucleotide targeting FOXP3 in regulatory T cells (Tregs), with a human IC50 of 65.2 nM. AZD8701 binds to intronic sites of all FOXP3 pre-mRNA isoforms and mediates dose-dependent FOXP3 knockdown via free uptake. AZD8701 can be used in cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 96.61%
- CAS. Nr.: 2603457-08-3
- Molecular Weight:5355.77
-
Speicherung:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
FOXP3 65.2 nM (IC50) |
AZD8701 (65 nM) potently knocks down FOXP3 in primary human Tregs (IC50 65 nM) via free uptake, reduces expression of key FOXP3 target genes by 25-50%, and impairs Treg suppressive function in vitro[1].
AZD8701 (0.001-10 μM; 9 days) potently reduces FOXP3 protein expression in primary human Tregs (EC50 = 44 nM, IC50 = 65.2 nM) and downregulates FOXP3-dependent immunosuppressive biomarkers CTLA4, ICOS, GITR, and CCR8 at 1 μM[2].
AZD8701 (1 μM; 9 days) strongly reduces FOXP3 protein expression in human thymic natural Tregs and effector Tregs subsets from healthy donor PBMCs[2].
AZD8701 reduces the suppressive function of human inducible Tregs in an in vitro effector T cell proliferation assay[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
AZD8701 (6.25-50 mg/kg; s.c.; daily; 4 days) drives dose-dependent knockdown of FOXP3 mRNA and protein in human Tregs in humanized NSG mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) (female, engrafted with 1×107 human peripheral blood mononuclear cells)[2]
-
Dosage:6.25 mg/kg; 12.5 mg/kg; 25 mg/kg; 50 mg/kg
-
Administration:s.c.; daily; 4 days
-
Result:Promoted dose-dependent knockdown of FOXP3 mRNA in splenic human Tregs.
Promoted significant downregulation of FOXP3 protein levels in splenic, blood, and bone marrow human Tregs at 25 mg/kg, reducing the percentage of FOXP3+ CD4+ T cells in spleen.
Chemical Information
-
CAS. Nr. 2603457-08-3
-
Appearance Solid
-
Molecular Weight 5355.77
-
Color White to off-white
-
SMILES
[AZD8701]
-
Synonyms
IONIS-1063734
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Reinheit & Dokumentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2242 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
AZD8701 Related Classifications
HY-159692 Related Classifications
Powered by Bioz